ALS LIMITED — Major Shareholding Notification 2022

Aug 14, 2022

Form 604

Corporations Act 2001 Section 671B

Notice of change of interests of substantial holder

ToCompany Name/Scheme	ToCompany Name/Scheme	HRL Holdings Ltd	(HRL)
ACN/ARSN		ACN 120 896 371
1. Details of substantial holder (1)
Name		Australian Laboratory Services Pty. Ltd. (ACN 009 936 029) and ALS Limited (ACN 009 657 489)
ACN/ARSN (if applicable)		As above
There was a change in the interests of the
substantial holder on			12 / 08 / 2022
The previous notice was given to the company on			12 / 08 / 2022
The previous notice was dated			12 / 08 / 2022
2. Previous and present voting power
The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an
relevant interest(3)in when last required,and when now required,togive a substantial holdingnotice to the companyor scheme,are as follows:
	Class of securities (4)Previous notice				Present notice
		Person’s votesVoting power(5)			Person’s votes	Voting power
	Fully paid ordinary shares in HRL459,560,81092.61%				473,825,931	95.49%
3. Changes in relevant interests
Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the
scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:
	Date of change	Person whose	Nature of change (6)	Consideration	Class and number of	Person’s votes
		relevant interest		given in relation	securities affected	affected
		changed		to change (7)
	12 / 08 / 2022	Australian Laboratory	Acquisition of fully	$2,282,419.36	14,265,121 fully paid	14,265,121
		Services Pty. Ltd.	paid ordinary shares	(being $0.16 per	ordinary shares in
		(ACN 009 936 029)	in HRL by Australian	fully paid ordinary	HRL
			Laboratory Services	share in HRL)
			Pty. Ltd. (ACN 009
			936 029) by on-
			market purchase
	12 / 08 / 2022	ALS Limited (ACN 009	Acquisition of fully	$2,282,419.36	14,265,121 fully paid	14,265,121
		657 489)	paid ordinary shares	(being $0.16 per	ordinary shares in
			in HRL by Australian	fully paid ordinary	HRL
			Laboratory Services	share in HRL)
			Pty. Ltd. (ACN 009
			936 029) by on-
			market purchase

4. Present relevant interests

Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:

Holder of relevantinterest	Registeredholder ofsecurities	Person entitled to beregistered as holder (8)	Nature of relevantinterest (6)	Class and number ofsecurities	Person’s votes
Australian LaboratoryServices Pty. Ltd. (ACN009 936 029)	AustralianLaboratoryServices Pty. Ltd.(ACN 009 936029)	Australian LaboratoryServices Pty. Ltd. (ACN009 936 029)	Registered holderof securities -Section 608(1)(a)of the_Corporations_Act 2001(Cth)	473,825,931 fully paidordinary shares in HRL	473,825,931
ALS Limited (ACN 009657 489)	AustralianLaboratoryServices Pty. Ltd.(ACN 009 936029)	Australian LaboratoryServices Pty. Ltd. (ACN009 936 029)	Relevant interest insecurities held by abody corporate inwhich the person'svoting power isabove 20% (ALSLimited (ACN 009657 489) has votingpower above 20%in AustralianLaboratoryServices Pty. Ltd.(ACN 009 936029)) - Section608(3)(a) of theCorporations Act2001(Cth)	473,825,931 fully paidordinary shares in HRL	473,825,931

5. Changes in association

The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable)	Nature of association
N/A - no changes from the previous notice	N/A - no changes from the previous notice
N/A - no changes from the previous notice	N/A - no changes from the previous notice

6. Addresses

The addresses of persons named in this form are as follows:

Name	Address
Australian Laboratory Services Pty. Ltd. (ACN 009 936029)	Level 2, 299 Coronation Drive, Milton, Queensland, 4064
ALS Limited (ACN 009 657 489)	Level 2, 299 Coronation Drive, Milton, Queensland, 4064

Signature

	Michael Paul Pearson	capacity	Company secretary of
			Australian Laboratory
			Services Pty. Ltd. (ACN 009
			936 029) and ALS Limited
			(ACN 009 657 489)
		date	15 / 08 / 2022

print name Michael Paul Pearson

sign here

DIRECTIONS

• (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.

• (2) See the definition of "associate" in section 9 of the Corporations Act 2001.

• (3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

• (4) The voting shares of a company constitute one class unless divided into separate classes.

• (5) The person’s votes divided by the total votes in the body corporate or scheme multiplied by 100.

• (6) Include details of:

(any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any adocument setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or )arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

(any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to bwhich the relevant interest relates (indicating clearly the particular securities to which the qualification applies). )

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

• (7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included on any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

• (8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write “unknown’”.

• (9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.